Newsfeeds Archive - Spark Newswire

4 minute read

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

June 20, 1:26 PM

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday’s session following third-quarter results. Jabil reported third-quarter fiscal 2024…

ALUR

2 minute read

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday

By Avi Kapoor

May 6, 1:05 PM

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of Spirit Airlines,…

ALLG

2 minute read

Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying

By Avi Kapoor

February 12, 9:36 AM

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

AON

3 minute read

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

February 6, 2:17 PM

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results.

AEY

1 minute read

Jasper Therapeutics Announces Pricing Of $50M Underwritten Offering Of 3.9M Shares Of Common Stock At A Price Of $12.95/Share

By Benzinga Newsdesk

February 6, 10:01 AM

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper"), a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria

JSPR

1 minute read

Jasper Therapeutics Announces Preclinical Data Presentations At American Academy of Allergy, Asthma, and Immunology Annual Meeting

By Benzinga Newsdesk

February 5, 9:11 AM

etails of the presentations are as follows:Abstract Title: Briquilimab, An Anti-CD117 Antibody, Prevents Passive Systemic Anaphylaxis in Mice Expressing Chimeric Human and Mouse CD117 Through Mast Cell

JSPR

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

January 18, 1:31 PM

Gainers Celularity (NASDAQ:CELU) shares moved upwards by 44.7% to $0.27 during Thursday’s regular session. The company’s market cap…

ARAV

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

January 17, 1:31 PM

Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 26.1% to $3.33 during Wednesday’s regular session. The company’s market…

ACXP

3 minute read

Jasper Announces First Patient Dosed In Phase 1b/2a Clinical Study Of Briquilimab In Chronic Spontaneous Urticaria

By Benzinga Newsdesk

November 30, 9:08 AM

Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) in mast cell-driven diseases such as chronic spontaneous

JSPR